Literature DB >> 1465

Production and purification of the gamma haemolysin of Staphylococcus aureus 'Smith 5R'.

H B Fackrell, G M Wiseman.   

Abstract

The gamma haemolysin of Staphylococcus aureus 'Smith 5R' was produced on Dolman-Wilson agar overlain with cellophane. Maximal yields of crude lysin with titres of 2000 to 4000 haemolytic units/ml were obtained within 24 h at 37 degrees C in 10% (v/v) CO2 in air, on medium adjusted to pH 7-0. The crude lysin was purified 2700-fold (with 75% recovery) by ultrafiltration, gel filtration and ammonium sulphate fractionation. The specific activity of the lysin was 10(5) haemolytic units/mg protein after the dialysed active precipitate was extracted with NaCl and reprecipitated with ammonium sulphate. Purified gamma lysin was homogeneous by disc electrophoresis and immunoelectrophoresis.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1465     DOI: 10.1099/00221287-92-1-1

Source DB:  PubMed          Journal:  J Gen Microbiol        ISSN: 0022-1287


  5 in total

Review 1.  Nonenteric toxins of Staphylococcus aureus.

Authors:  M Rogolsky
Journal:  Microbiol Rev       Date:  1979-09

Review 2.  Staphylococcus aureus pore-forming toxins: The interface of pathogen and host complexity.

Authors:  E Sachiko Seilie; Juliane Bubeck Wardenburg
Journal:  Semin Cell Dev Biol       Date:  2017-04-23       Impact factor: 7.727

Review 3.  The bicomponent pore-forming leucocidins of Staphylococcus aureus.

Authors:  Francis Alonzo; Victor J Torres
Journal:  Microbiol Mol Biol Rev       Date:  2014-06       Impact factor: 11.056

4.  Plasmid cistrons controlling synthesis and excretion of the exotoxin alpha-haemolysin of Escherichia coli.

Authors:  A Noegel; U Rdest; W Springer; W Goebel
Journal:  Mol Gen Genet       Date:  1979-10-01

Review 5.  The Role of Streptococcal and Staphylococcal Exotoxins and Proteases in Human Necrotizing Soft Tissue Infections.

Authors:  Patience Shumba; Srikanth Mairpady Shambat; Nikolai Siemens
Journal:  Toxins (Basel)       Date:  2019-06-11       Impact factor: 4.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.